
News|Articles|June 1, 2008
Drug Watch: Agents in late-stage development for the treatment of bipolar disorder and psychosis (June 2008) (PDF)
Drugs in development for the treatment of bipolar disorder and psychosis
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Centanafadine hits primary and key secondary endpoints in ADHD phase 3b trial
3
Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma
4
A conversation about vaccines and monoclonal antibodies with Marc Elia, Chairman of Invivyd’s Board of Directors
5
































